First Look Analysts Research Calls for Monday, December 19
This report was sent to Briefing.com subscribers earlier today. Upgrades: > American Equity Investment Life (AEL) upgraded to Strong Buy from Outperform at Raymond James; tgt $48 > Enphase Energy (ENPH) upgraded to Outperform from Market Perform at Northland Capital;…
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> American Equity Investment Life (AEL) upgraded to Strong Buy from Outperform at Raymond James; tgt $48
> Enphase Energy (ENPH) upgraded to Outperform from Market Perform at Northland Capital; tgt $365
> Glaukos (GKOS) upgraded to Neutral from Underweight at JP Morgan; tgt lowered to $42
> Moderna (MRNA) upgraded to Buy from Hold at Jefferies; tgt raised to $275
> Pentair (PNR) upgraded to Buy from Hold at Stifel
> PerkinElmer (PKI) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $170
> Verizon (VZ) upgraded to Market Perform from Underperform at MoffettNathanson; tgt $41
Downgrades:
> Ameriprise Financial (AMP) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $325
> AT&T (T) downgraded to Underperform from Market Perform at MoffettNathanson; tgt $17
> AXIS Capital (AXS) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $60
> Baxter (BAX) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $55
> Catalent (CTLT) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> L3Harris (LHX) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $241
> Louisiana-Pacific (LPX) downgraded to Hold from Buy at TD Securities; tgt $72
> Tesla (TSLA) downgraded to Perform from Outperform at Oppenheimer
> Vertex Pharma (VRTX) downgraded to Hold from Buy at Jefferies; tgt $340
> VTEX (VTEX) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $5
> Xylem (XYL) downgraded to Hold from Buy at Stifel; tgt raised to $115
Others:
> Annaly Capital Mgmt (NLY) initiated with a Buy at Jones Trading; tgt $22.50
> Bank of Montreal (BMO) resumed with an Outperform at Credit Suisse
> DZS Inc. (DZSI) initiated with an Outperform at Cowen; tgt $25
> Main Street Capital (MAIN) initiated with a Neutral at UBS; tgt $40
> MasterBrand (MBC) initiated with a Hold at Loop Capital; tgt $9
> NewAmsterdam Pharma (NAMS) initiated with a Buy at Jefferies; tgt $24
> NewAmsterdam Pharma (NAMS) initiated with an Outperform at William Blair
> Schrodinger (SDGR) initiated with a Neutral at Goldman; tgt $23
> Thomson Reuters (TRI) assumed with a Sector Perform at Scotiabank; tgt $126
> VersaBank (VBNK) assumed with an Outperform at Raymond James; tgt $9
> Viridian Therapeutics (VRDN) initiated with an Outperform at Cowen; tgt $45
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.